Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 17

Skylo escapes stealth with $116m

SoftBank has led a $103m series B round for the IoT network and hub developer, a spinout of Stanford, that made up one of two rounds it has raised.

Jan 21, 2020

Inscripta cribs $125m in series D round

CU Boulder spinout Inscripta has now accumulated more than $259m from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.

Dec 18, 2019

CureFit starts training for $100m round

Temasek could reportedly invest in CureFit at a valuation of $800m, three years after UC-RNT Fund supplied $25m to the wellness services provider.

Dec 3, 2019

PsiQuantum swings $230m

University of Bristol-founded PsiQuantum has reportedly scooped funding from backers including an Andy Rubin fund as it looks to develop silicon-powered quantum computers.

Nov 19, 2019

eGenesis brings about $100m series B

Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.

Nov 8, 2019

Databricks builds $400m series F

Andreessen Horowitz has led a $400m round for the data preparation software provider based on UC Berkeley research, more than doubling its valuation to $6.2bn in eight months.

Oct 23, 2019

CMR Surgical completes $240m series C operation

Cambridge Innovation Capital has returned a second time to back a $240m series C for CMR Surgical, helping bring the surgical robotics company's total funding to $386m.

Sep 18, 2019

Trifacta wrangles $100m

Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.

Sep 13, 2019

CAS helps GKHT source $154m

Cash Capital has contributed to a a series C round for medical supplies provider GKHT, established as an affiliate of the Chinese Academy of Sciences-owned Osic Holding Group.

Sep 9, 2019

Passage Bio packs in another $110m

University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

Sep 5, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here